Applications are being accepted for an innovative new four-year college program at the University of California, Davis (UC…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
Fathers or male caregivers of children with fragile X syndrome are invited to contribute to a U.K. film project…
Rare Disease Day at NIH, organized by the National Institutes of Health (NIH) and taking place on March 1,…
Scores of virtual events are afoot around the world to mark Rare Disease Day 2021 on Feb. 28. The…
While progress was made last year on newborn screening and other policy issues critical to rare disease patients, a “…
Butterflies, ballerinas, and abstract flowers are featured among the winning artwork of this year’s Rare Artist contest, hosted by…
Caring for a loved one with a rare disease, especially during these uncertain times, demands significant time, attention, patience, and…
The National Organization for Rare Disorders (NORD) is seeking individuals willing to share real-life experiences with rare diseases to…
Confluence Pharmaceuticals will use a $100,000 investment to further its development of ACP, an investigational therapy that aims to…
To empower and equip members of the rare disease community to engage state leaders in matters of importance to patients…